Skip to content
This GLP
Updated September 2026Illustrative, by its own label

Science & Co review

The member statistics carry a line underneath calling them illustrative.

The verdict

Science & Co leads each product page with its twelve-month rate and discloses that term itself, in an FAQ answer a few scrolls below the price. The four member statistics on the same page sit above a line reading "Illustrative outcomes", which is the site telling a reader those figures are not measurements of its own patients.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
Dose pricing
Flat across doses
From
From $89/mo
Dose published
No
Prescription
Required
Compounded
Yes — not FDA-approved
Pharmacy
Not named

Science & Co sells compounded semaglutide and compounded tirzepatide by weekly injection, prepared by a state-licensed U.S. compounding pharmacy. Sermorelin, glutathione and three brand-name GLP-1s are listed as coming soon. Hormone replacement and longevity protocols share the same platform. The company states it is not itself a 503A or 503B facility.

  1. Who writes the prescription, and what do they see?

    A five-minute intake goes to a provider licensed in the buyer's state, and the site states nothing is dispensed without that provider's approval. Monthly check-ins are described, with dose adjustments made at them. The page names no provider, medical group or medical director, so the clinician relationship is asserted rather than evidenced.

    Four steps run from quiz to delivery, entirely online, with a concierge team stated to be available at any hour. Progress logging feeds back to the provider, who is described as adjusting from it. Plain-language guides written by the clinical team are published free. Batch testing for purity and potency is claimed as third-party.

  2. What happens when the dose goes up?

    This is the part the site answers directly. A dedicated FAQ states the price does not rise at any dose, from the starting one to the highest. Side effects are described as usually nausea and usually early, appearing in the weeks after a step up and settling within a week or two. If they do not settle, the stated response is to slow the climb rather than stop it, which is a more specific commitment than most of this category makes.

  3. What the price includes

    Month to month, semaglutide is $89 and tirzepatide is $139. Three-, six- and twelve-month tiers sit under each, taken as one upfront charge: $250, $486 and $948 for semaglutide. The product page leads with the twelve-month equivalent and a struck-through figure beside it. The struck figure does not correspond to any rung named on the page.

  4. What it claims, and what it cites

    Both lines are compounded rather than manufactured, and the site states plainly that compounded medications are not evaluated by the FDA for safety, quality or efficacy. The preparing pharmacy is described as state-licensed but is not named. Brand trademarks are disclaimed in the footer.

Where it holds up, and where it does not

  • Strength: One price across the whole dose ladder
  • Strength: The twelve-month term is disclosed in the FAQ
  • Strength: Every prepay total is published, not just the rate
  • Strength: Dose-increase side effects get a specific answer
  • Strength: Outcome figures are labeled illustrative
  • Limitation: The headline rate is a year paid upfront
  • Limitation: The struck-through figure matches no rung
  • Limitation: The compounding pharmacy is not named
  • Limitation: No provider or medical group is named
  • Limitation: No milligram dose appears beside a price

What the evidence says about this kind of treatment

The assessment above is about Science & Co. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A buyer who wants a flat rate across the dose ladder and will read the FAQ for the term.
Wrong for
A buyer who takes a headline figure as the month-to-month rate.

How Science & Co compares

SellerWho it suitsGo
FitFlowBuyers who read the plan table before the page title and want the whole ladder in one placeSee FitFlow
CieloBuyers who want the commitment behind a headline rate spelled out in the asterisk under itSee Cielo
Ondra HealthBuyers who want the billed total printed beside the monthly figure before they choose a termSee Ondra Health
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: PeterMDPiperPlexusDxPlushCarePotere Health MDPreventiveMD

Sponsored alternative

Bodybuilding Health+

A reader unwilling to prepay a year before seeing how the drug goes

Check Bodybuilding Health+ availability →

Frequently asked

Is the headline rate a monthly price?
It is the twelve-month plan. The site's own FAQ says so on the same page, and quotes the month-to-month rate separately at $89.
Does the price rise as the dose goes up?
No. Science & Co states the same rate applies from the starting dose to the highest one, with no membership fee beside it.
Are the member statistics measured?
No. A line directly beneath them reads "Illustrative outcomes. Individual results vary."
Is Science & Co expensive compared with other GLP-1 telehealth sellers?
Science & Co publishes a starting figure of $89/mo. Across the 252 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $399 with a median of $178, which puts Science & Co below the median, toward the cheaper end. The other 19 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Dana SullivanEvidence reviewer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from Science & Co’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.